SCHEMBL23966522

SCHEMBL23966522

CCCCOC(=O)Cc1n[nH]c2ccccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.56
KDM4E B2RXH2 9/20 0.56
HSD17B10 Q99714 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.53
TSHR P16473 4/20 0.50
HPGD P15428 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
GAA P10253 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23909017 0.83 SMN1; SMN2 (0.66) ALDH1A1KDM4EHSD17B10SMN1; SMN2CYP1A2
SCHEMBL23914670 0.80 SMN1; SMN2 (0.48) ALDH1A1KDM4ESMN1; SMN2HPGDCYP1A2
SCHEMBL1989361 0.79 SMN1; SMN2 (0.72) ALDH1A1KDM4EHSD17B10SMN1; SMN2LMNA
SCHEMBL23908935 0.77 LMNA (0.62) ALDH1A1KDM4ESMN1; SMN2HPGDCYP1A2
SCHEMBL21591507 0.73 CYP1A2 (0.58) ALDH1A1KDM4ESMN1; SMN2HPGDCYP1A2
SCHEMBL8766823 0.73 ALDH1A1 (0.79) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL4300704 0.73 SMN1; SMN2 (0.71) ALDH1A1KDM4EHSD17B10SMN1; SMN2MAPT
SCHEMBL11133828 0.72 ALDH1A1 (0.46) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL5010738 0.69 SMN1; SMN2 (1.00) ALDH1A1KDM4EHSD17B10SMN1; SMN2TSHR
SCHEMBL3716680 0.69 KDM4E (0.81) ALDH1A1KDM4EHSD17B10SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed